Avidity Biosciences, Inc.
Pharmaceutical company · San Diego, California, United States
Avidity Biosciences, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2019. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $200,000 in total, most recently in 2013. It has reported private securities offerings to the US SEC, most recently $400 million sold in a notice filed in 2024.
Avidity Biosciences at a glance
What does Avidity Biosciences do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $200,000 in total (2013).
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $400.2 million sold (2024).
Frequently asked questions about Avidity Biosciences
Where is Avidity Biosciences headquartered?
Avidity Biosciences, Inc. is headquartered in San Diego, California, United States.
What does Avidity Biosciences do?
Avidity Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Avidity Biosciences founded?
The earliest incorporation on record for Avidity Biosciences, Inc. is in 2019, according to public company registers.
Similar companies
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Oncternal Therapeutics, Inc.San Diego, California, United States
- Acadia Pharmaceuticals IncSan Diego, California, United States
- ViaCyte Inc.San Diego, California, United States
- Ligand Pharmaceuticals IncSan Diego, California, United States
- Arena Pharmaceuticals IncSan Diego, California, United States
- Kura Oncology, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.